Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about BAYER
10:18a BAYER : rivaroxaban submitted to U.S. FDA for approval in patients with coronary..
04:09aDJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/11 Monsanto offers cash to U.S. farmers who use controversial chemical
12/08 EU regulators to warn Bayer about Monsanto bid
12/07 BAYER : New Bayer transparency website launched
12/07 BAYER : Many disease-causing pathogens that are transferable from pets to humans..
12/07 BAYER : Linde 50th anniversary
12/06DJBAYER : Johnson & Johnson Ordered to Pay $27.8 Million in Xarelto Lawsuit -Reute..
12/05 BAYER : Jury orders Bayer, Johnson & Johnson to pay $28 million in Xarelto lawsu..
12/05 BAYER : Court sides with Missouri woman who claims she was harmed by Bayer birth..
12/04 LOXO ONCOLOGY : Bayer invests in differentiated drug pipeline with over 50 proje..
12/04 SHIRE : Busch joining Shire as head of R&D
12/01DJSHIRE : Appoints New Chief Scientific Officer, Chief Medical Officer
12/01DJBAYER : Gets CFIUS Clearance for Monsanto Deal
12/01DJBAYER : Unblinds Early Phase 3 Anti-Cancer Drug Trial
More most relevant news
All news about BAYER
10:18a BAYER : rivaroxaban submitted to U.S. FDA for approval in patients with coronary..
04:09aDJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/11 Monsanto offers cash to U.S. farmers who use controversial chemical
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 BAYER : Preventive Maintenance & service solution on existing Bayer/Medrad and A..
12/08 BAYER : J-- Preventive Maintenance & service solution on existing Bayer/Medrad a..
12/07 'Right steps' point to a healthier China
12/07 BAYER : Research Conducted at Bayer Has Provided New Information about Atrial Fi..
12/07 BAYER : Findings from Bayer Has Provided New Data on Liver Cancer (Exposure-resp..
12/07 BAYER : New Findings from Bayer in Antibiotics Provides New Insights (Physiologi..
More news
Sector news : Pharmaceuticals - NEC
02:08p TEVA PHARMACEUTICAL INDUSTRIES : Fears of Israeli job cuts at Teva sparks call f..
10:24a France's Sanofi pins hopes on new drugs after setbacks
07:32aDJELI LILLY AND : Sees Modest Revenue Growth in 2018
07:16a SANOFI : CEO says M&A targets in oncology are 'very expensive'
03:55aDJSANOFI : to Begin at Least 10 Phase 3 Studies Over Next 12 Months
12:47a SANOFI : Did Sanofi, WHO ignore warning signals on dengue vaccine?
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12/11 Buy Celgene And Regeneron On The Dips As Insiders Are Buying
12/08 BLOOMBERG : Bayer to face EU objections to Monsanto deal in coming days
12/07 COBAS ASSET MANAGEMENT : Comments On Third Quarter 2017
12/06 You Get A Dilution! You Get A Dilution! What About CRISPR Therapeutics?
12/05 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 5, 2017
12/02 3 THINGS IN BIOTECH YOU SHOULD LEARN : December 2, 2017
Financials (€)
Sales 2017 35 698 M
EBIT 2017 7 647 M
Net income 2017 6 050 M
Debt 2017 8 890 M
Yield 2017 2,47%
P/E ratio 2017 14,05
P/E ratio 2018 18,38
EV / Sales 2017 2,72x
EV / Sales 2018 2,48x
Capitalization 88 194 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 121 €
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER5.62%102 387
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.01%218 773
PFIZER10.04%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659